Novartis now in top highest dividend yields in Switzerland

Investors in Novartis can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts expect a dividend of 3.5 CHF per share. The dividend yield is then 4.03 percent. The average dividend yield of the pharmaceutical companies is a relatively high 2.07 percent.

Historical dividend returns Novartis

Tomorrow the Swiss company Novartis will publish its past quarters results. Over the current book year the total revenue from the company in will be 52.39 billion CHF (consensus estimates). This is slightly more than 2022's revenue of 51.74 billion CHF.

Historical revenues and results Novartis plus estimates 2023

The analysts expect for 2023 a net profit of 13.57 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 6.6 CHF. So the price/earnings-ratio equals 13.14.

Recent target prices around 88 CHF

Novartis 's market capitalization is based on the number of outstanding shares around 193.88 billion CHF.

Historical stock prices Novartis

At 14.54 the stock trades 0.15 percent higher at 86.75 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.